Background
Methods
Settings
Data collection
Focus group methods and development of survey
Procedure
Analysis
Results
Characteristics | Hospital A (N = 87) | Hospital B (N = 63) |
---|---|---|
Gendera
| ||
Male | 18 (21 %) | 20 (32 %) |
Female | 66 (76 %) | 42 (67 %) |
Missing | 3 (3 %) | 1 (2 %) |
Agea
| ||
Less than 25 | 5 (6 %) | 2 (3 %) |
Between 25 and 34 | 41 (47 %) | 23 (37 %) |
Between 35 and 44 | 19 (22 %) | 14 (22 %) |
Between 45 and 54 | 16 (18 %) | 17 (27 %) |
More than 55 | 3 (3 %) | 6 (10 %) |
Missing | 3 (3 %) | 1 (2 %) |
Job positiona
| ||
Nurses | 30 (35 %) | 27 (43 %) |
Pharmacists | 22 (25 %) | 4 (6 %) |
Respiratory therapists | 34 (39 %) | 15 (24 %) |
Physicians | 1 (1 %) | 17 (27 %) |
Work shift b
| ||
7 am – 7 pm | 40 (46 %) | 36 (57 %) |
7 pm – 7 am | 18 (21 %) | 15 (24 %) |
7 am – 3 pm | 19 (22 %) | 13 (21 %) |
3 pm – 11 pm | 8 (9 %) | 10 (16 %) |
11 pm – 7 am | 7 (8 %) | 5 (8 %) |
Average length working for the present employer | 10.5 years | 9.2 years |
Average length working in the current position | 8.8 years | 8.8 years |
Barriers and facilitators
Barriers | Percent | Response category |
---|---|---|
Having multiple physician groups manage patients in the ICU complicates VAP guideline use. | 67.3 % | Agree & strongly agree |
There is variation in VAP management depending on what service the ICU patient is on. | 64.3 % | Agree & strongly agree |
ICU patients with renal failure complicate decision-making when ordering antibiotics. | 57.4 % | Agree & strongly agree |
Within physician service there is variation in VAP management depending on who is the VAP patient’s attending physician. | 56.8 % | Agree & strongly agree |
There is variation in VAP management between attending physicians and house staff in the ICU. | 52.6 % | Agree & strongly agree |
Facilitators | Percent | Response category |
---|---|---|
Pharmacist participation on ICU rounds is beneficial. | 98.60 % | Agree & strongly agree |
Nurse participation on ICU rounds is beneficial. | 98.00 % | Agree & strongly agree |
Respiratory therapist participation on ICU rounds is beneficial. | 96.70 % | Agree & strongly agree |
I can readily access orders that are written for my ICU patients. | 92.60 % | Agree & strongly agree |
Respiratory therapy services are readily available on my ICU. | 92.30 % | Fairly often & very often |
Multidisciplinary management of patients occurs on my ICU. | 91.90 % | Agree & strongly agree |
Nurses consistently participate on ICU patient rounds. | 90.30 % | Fairly often & very often |
Physicians are receptive to pharmacist input in ICU patient care. | 89.70 % | Agree & strongly agree |
Pharmacists on my ICU effectively monitor antibiotic use. | 89.30 % | Agree & strongly agree |
Pharmacist participation in ICU patient management promotes appropriate antibiotic ordering. | 89.00 % | Agree & strongly agree |
Pharmacists consistently participate on ICU patient rounds. | 88.10 % | Fairly often & very often |
It is effective to have pharmacists help determine the appropriateness of ICU antibiotic de-escalation. | 87.70 % | Agree & strongly agree |
I can readily access the information I want on my ICU patients in the EMR. | 86.90 % | Agree & strongly agree |
Using VAP management guidelines helps me to manage VAP patients in the ICU. | 86.70 % | Agree & strongly agree |
Pharmacy intervention in antibiotic ordering leads to effective ICU VAP management. | 86.30 % | Agree & strongly agree |
Respiratory therapists consistently participate on ICU patient rounds. | 83.20 % | Fairly often & very often |
I can appropriately manage ICU patients with VAP. | 83.10 % | Agree & strongly agree |
VAP management guidelines interfere with my ability to manage my ICU patients. | 82.30 % | Occasionally & rarely |
Aware of IDSA/ATS guideline for VAP management | Total | |||
---|---|---|---|---|
Yes | No | Missing | ||
Physicians | 8 | 10 | 0 | 18 |
Nurses | 30 | 22 | 5 | 57 |
Respiratory therapists | 22 | 17 | 10 | 49 |
Pharmacists | 23 | 3 | 0 | 26 |
Total | 83 | 52 | 15 | 150 |
Theme | Item | Mean Rank |
P-Value |
---|---|---|---|
Communication between providers | They would benefit by receiving clinical progress reports feedback on VAP patients after they are discharged from the ICU | Physicians vs. respiratory therapists, 43.1 vs 72.4 | 0.03 |
Physicians vs. pharmacists, 43.1 vs 85.2 | 0.02 | ||
Could more readily access information on ICU patients from the EMR | Respiratory therapists vs. nurses, = 62.8 vs 85.0 | 0.02 | |
Difficulty in diagnosing VAP | Being able to perform a bronchoscopy in the ICU helps the physician to expeditiously diagnose VAP | Physicians aware of the guideline vs. those not aware of it, 57.4 vs 68.7 | 0.05 |
Education related to VAP and VAP management | Received effective training on VAP management | Participants aware of the guideline vs. those not aware of it, 56.7 vs 83.6 | <.01 |
Kept up-to-date on nosocomial infection literature | Participants aware of the guideline vs. those not aware of it, 54.73 vs 85.81 | <.001 | |
Could appropriately manage ICU patients with VAP | Participants aware of the guideline vs. those not aware of it, 58.14 vs 71.35 | 0.01 | |
Believe that they could easily interpret quantitative culture results related to VAP (applicable to physicians only)
| Participants aware of the guideline vs. those not aware of it, 55.92 vs 72.17 | 0.01 | |
Believe that they could accurately diagnose ICU patients with VAP (applicable to physicians only)
| Participants aware of the guideline vs. those not aware of it, 41.81 vs. 53.16 | 0.03 | |
Kept up-to-date on nosocomial infection literature | Pharmacists vs. nurses, 58.8 vs 83.9 | <.01 | |
Guideline awareness and use | ICU VAP management order sets would facilitate VAP management | Pharmacists vs. respiratory therapists, 51.5 vs 88.5 | <.01 |
Physicians vs. respiratory therapists, 54.6 vs 88.5 | <.01 | ||
VAP management guidelines interfere with their ability to manage my ICU patients | Respiratory therapists vs. pharmacists, 44.0 vs 72.1 | <.01 | |
Management of the condition | Having nurses float between ICUs interferes with standardized VAP patient management | *Participants aware of the guideline vs. those not aware of it, 70.1 vs 57.5 | <.001 |
Physicians are receptive to respiratory therapist input in ICU patient care | Physicians vs. respiratory therapists, 56.0 vs 87.9 | <.01 | |
Physicians are receptive to pharmacists’ input in ICU patient care | Physicians vs. respiratory therapists, 52.3 vs 79.5 | 0.02 | |
ICU patients with renal failure complicate decision-making when ordering antibiotics | Physicians vs. pharmacists, 35.6 vs 70.7 | <.01 | |
Physicians vs. respiratory therapists, 35.6 vs 79.2 | <.01 | ||
Nurses respiratory therapists, 56.1 vs 79.2 | 0.02 | ||
Provider responsibilities | It is effective to have pharmacists help determine the appropriateness of ICU antibiotic de-escalation | Participants aware of the guideline vs. those not aware of it, 57.8 vs 73.2 | <.001 |
Pharmacists vs. respiratory therapists, 49.9 vs 82.5 | <.01 | ||
Attending physicians should be responsible for educating house staff on VAP management guidelines | Participants aware of the guideline vs. those not aware of it, 61.6 vs 74.5 | 0.04 | |
Respiratory therapy does not respond promptly to mini-BAL orders for ICU patients with suspected VAP | Participants aware of the guideline vs. those not aware of it, 51.54 vs 41.3 | 0.05 | |
Pharmacy intervention in antibiotic ordering leads to effective ICU VAP management | Pharmacists vs. respiratory therapists, 50.5 vs 86.2, | <.01 | |
Nurses vs. respiratory therapists, 67.8 vs 86.2, | 0.04 | ||
Multidisciplinary management of patients occurs on their ICU | Pharmacists vs. respiratory therapists, 63.8 vs 88.1 | 0.04 | |
Pharmacists on their ICU effectively monitor antibiotic use | Pharmacists vs. respiratory therapists, 50.1 vs 82.9 | <.01 | |
Technology and its use | Having an electronic medical record (EMR) reduces the time necessary to diagnose VAP in the ICU | Physicians vs. nurses, 42.6 vs 75.9 | 0.04 |
Physicians vs. pharmacists, 42.6 vs 76.8 | 0.02 | ||
Use of clinically indicated tests | ICU respiratory therapists are capable of performing mini-BALs | *Participants aware of the guideline vs. those not aware of it, 63.8 | 0.03 |
ICU respiratory therapists are capable of performing mini-BALs | Respiratory therapists vs. pharmacists, 49.3 vs 84.2 | <.01 | |
More clinically useful specimens are collected when mini-BALs are performed | Respiratory therapists vs. physicians, 49.3 vs 91.1 | <.01 | |
Variation in practice | There is variation in VAP management depending on what service the ICU patient was on | Pharmacists vs. respiratory therapists, 47.9 vs 84.3 | <.01 |
There is variation in VAP management depending on who the VAP patient’s attending physician was | Pharmacists vs. respiratory therapists, 52.3 vs 79.8 | <.01 | |
There is variation in VAP management between attending physicians and house staff in the ICU | Pharmacists vs. respiratory therapists44.2 vs 75.5 | <.01 | |
Pharmacists vs. nurses, 44.2 vs 76.0 | <.01 | ||
Antibiotic ordering practices vary between house staff and attending physicians in the ICU | Respiratory therapists vs. pharmacists, 33.7 vs 63.2 | 0.02 | |
Respiratory therapists vs. physicians, 33.7 vs 64.3 | |||
Respiratory therapists vs. physicians, 33.7 vs 64.3 | 0.03 | ||
Nurses vs. pharmacists, 45.0 vs 63.2 | 0.04 |